A to Z

neuropsychopharmacology

This shows two heads with a psychedelic background

Featured Neuroscience Open Neuroscience Articles Psychology

·May 30, 2019·4 min read

‘Ecstasy’ shows promise for post-traumatic stress treatment

MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.

Featured Neuroscience Open Neuroscience Articles Psychology

·December 9, 2022·4 min read

A Better Understanding of How the Most Commonly Used ADHD Medication Works

Study reveals how methylphenidate interacts with cognitive control networks and attention behaviors. Methylphenidate changes spontaneous neural activity in reward and cognitive control systems in children with ADHD. The changes result in more stable sustained attention.

This cartoon shows a brain with a lock around it and a man holding a key

Featured Neuroscience Open Neuroscience Articles Psychology

·April 14, 2022·5 min read

A Drug That Cures Alcoholism May Be the Next Anti-anxiety Medication

Disulfiram, a drug commonly prescribed to treat chronic alcohol addiction, was shown to reduce anxiety levels in rodent models. The drug inhibits FROUNT protein and chemokine signaling pathways under its influence, suppressing overall glutamate transmission in the brain. This, in turn, helps reduce overall activity. The findings may signal a new way to treat anxiety in humans.

This image shows the anatomy to the VTA with the striatum, nucleus accumbens and substantia nigra labelled.

Featured Psychology

·July 21, 2015·3 min read

A New Target For Depression Treatment

Researchers have identified a potential new target to treat recurring depression.

This image shows the location of the prefrontal cortex.

Featured Psychology

·March 5, 2015·4 min read

Abnormal Brain Rhythms Tied to Problems with Thinking in Schizophrenia

Using a unique mouse model, researchers show cognitive deficits associated with schizophrenia may be reversible.

Featured Psychology

·March 15, 2018·5 min read

ADHD Drug Increases Glutamate and Positive Emotion in Healthy People

A new study reveals a psychostimulant prescribed for ADHD increases glutamate in the brains of healthy people, resulting in more positive emotions.

Image shows a girl holding her head in her hands.

Featured Psychology

·January 3, 2018·5 min read

ADHD Increases STI Risk, But Medications May Help Reduce It

A new study reveals ADHD increases the risk of sexually transmitted infections in adolescents threefold compared to the general population. However, the use of ADHD medications reduces the risk of STIs in males by up to 41%.

This shows Vyvanse (Lisdexamfetamine) 70mg capsules

Featured Neuroscience Psychology

·November 17, 2022·5 min read

ADHD Medication for Amphetamine Addiction Linked to Reduced Risk of Hospitalization and Death

Lisdexamfetamine (Vyvanse), a medication commonly used to treat ADHD, lowers the risk of hospitalization and death for those with amphetamine use disorder.

Image shows a woman sitting at a table and two transparent men.

Featured Psychology

·February 3, 2016·4 min read

An Alternative Treatment Target For Schizophrenia

A new study suggests that dysregulation in the way two G protein-coupled receptors talk to each other may be responsible for some symptoms of schizophrenia.